Mark Lappe
CIK 1366074 · Chief Executive Officer · last filed 2024-09-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$65.05M
Companies
2
Total Filings
32
Lifetime Open-Market Net
-$1.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INBX | Chief Executive Officer | 705,548 | $92.20 | $65.05M | -$1.69M | 9 | 2024-09-16 |
| Inhibrx, Inc. (INBXV) Delisted | Chief Executive Officer | 0 | — | — | $0 | 1 | 2024-05-30 |
Recent Filings · Page 2 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-18 | INBX | Sell (S) | −52,000 | -$1.45M | EDGAR |
| 2009-12-21 | — | Sell (S) | −784,015 | -$528.5K | |
| 2009-12-02 | — | Sell (S) | −2,705,000 | -$1.90M | |
| 2009-11-23 | — | Sell (S) | −3,280,000 | -$2.36M | |
| 2009-05-22 | — | Grant (A) | — | $0 | |
| 2008-11-04 | — | Buy (P) | +11,300 | $87.7K | |
| 2008-10-30 | — | Buy (P) | +34,292 | $238.0K | |
| 2008-10-30 | — | Buy (P) | +205,752 | $1.43M | |
| 2008-10-27 | — | Buy (P) | +372,804 | $2.51M | |
| 2008-10-27 | — | Buy (P) | +62,134 | $417.6K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.